{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:26:16Z","timestamp":1793114776297,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.yebeh.2020.107489","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T06:14:04Z","timestamp":1605766444000},"page":"107489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy"],"prefix":"10.1016","volume":"113","author":[{"given":"Yi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107489_bb0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107489_bb0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.seizure.2012.10.002","article-title":"Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database","volume":"22","author":"Nicholas","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107489_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1212\/WNL.0b013e31825f0466","article-title":"Falls and fractures in patients chronically treated with antiepileptic drugs","volume":"79","author":"Shiek Ahmad","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107489_bb0025","first-page":"378","article-title":"Osteopathies in antiepileptic long-term therapy (preliminary report)","volume":"116","author":"Kruse","year":"1968","journal-title":"Monatsschr Kinderheilkd"},{"key":"10.1016\/j.yebeh.2020.107489_bb0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2014.04.018","article-title":"Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis","volume":"64","author":"Shen","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.yebeh.2020.107489_bb0035","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/epi.13893","article-title":"Impaired bone and muscle development in young people treated with antiepileptic drugs","volume":"58","author":"Simm","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107489_bb0040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/14740338.2019.1625887","article-title":"An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs","volume":"18","author":"Miziak","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.yebeh.2020.107489_bb0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database","volume":"21","author":"Nicholas","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107489_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032551","article-title":"Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records","volume":"9","author":"Powell","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2020.107489_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107489_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnmt.113.124685","article-title":"Antiepileptic treatment is associated with bone loss: difference in drug type and region of interest","volume":"41","author":"Salimipour","year":"2013","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clineuro.2016.04.019","article-title":"Bone health and vitamin D status in young epilepsy patients on valproate monotherapy","volume":"146","author":"Albaghdadi","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.yebeh.2020.107489_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.seizure.2019.10.017","article-title":"Effects of valproic acid on bone mineral density and bone metabolism: a meta-analysis","volume":"73","author":"Fan","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107489_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2009.12.015","article-title":"Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy","volume":"290","author":"Triantafyllou","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2020.107489_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2014.02.032","article-title":"The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism","volume":"340","author":"Simko","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2020.107489_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2018.02.010","article-title":"The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism","volume":"824","author":"Karesova","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/0004-282x20180068","article-title":"Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients","volume":"76","author":"El-Haggar","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2020.107489_bb0095","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107489_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107489_bb0105","doi-asserted-by":"crossref","first-page":"111409","DOI":"10.1117\/1.JBO.18.11.111409","article-title":"Epileptic seizure-induced structural and functional changes in rat femur and tibia bone tissues: a Fourier transform infrared imaging study","volume":"18","author":"Garip","year":"2013","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.yebeh.2020.107489_bb0110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0003702817734617","article-title":"Side-effects of convulsive seizures and anti-seizure therapy on bone in a rat model of epilepsy","volume":"72","author":"Garip Ustaoglu","year":"2018","journal-title":"Appl Spectrosc"},{"key":"10.1016\/j.yebeh.2020.107489_bb0115","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3389\/fphar.2019.01278","article-title":"Bone health in rats with temporal lobe epilepsy in the absence of anti-epileptic drugs","volume":"10","author":"Brady","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0120","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3389\/fneur.2019.01171","article-title":"Bone mineral density loss in people with epilepsy taking valproate as a monotherapy: a systematic review and meta-analysis","volume":"10","author":"Zhong","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pediatrneurol.2007.05.018","article-title":"Bone mineral density with lamotrigine monotherapy for epilepsy","volume":"37","author":"Sheth","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2016.10.005","article-title":"The effect of lamotrigine and phenytoin on bone turnover and bone strength: a prospective study in Wistar rats","volume":"128","author":"Simko","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107489_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2220\/biomedres.38.297","article-title":"Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats","volume":"38","author":"Kanda","year":"2017","journal-title":"Biomed Res"},{"key":"10.1016\/j.yebeh.2020.107489_bb0140","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/epi.12162","article-title":"Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy","volume":"54","author":"Phabphal","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107489_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yebeh.2015.06.025","article-title":"The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine","volume":"51","author":"Serin","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107489_bb0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.seizure.2012.04.002","article-title":"Bone mineral density in adult patients treated with various antiepileptic drugs","volume":"21","author":"Beniczky","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107489_bb0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1139\/cjpp-2013-0504","article-title":"Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice","volume":"92","author":"Anwar","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107489_bb0160","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.b17-00482","article-title":"Effects of the antiepileptic drugs phenytoin, gabapentin, and levetiracetam on bone strength, bone mass, and bone turnover in rats","volume":"40","author":"Kanda","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.yebeh.2020.107489_bb0165","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107489_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2013.08.012","article-title":"The effect of levetiracetam on rat bone mass, structure and metabolism","volume":"107","author":"Fekete","year":"2013","journal-title":"Epilepsy Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020306697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020306697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:33:23Z","timestamp":1761503603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020306697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":34,"alternative-id":["S1525505020306697"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107489","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107489"}}